« UK-Malaysia Export Opportunities - A Summary | Main | Date for Diaries: EU IP SME China and SE Asia Patent Webinar Wed 15.09.21 1000-1100 (CET) »

08 September 2021

AstraZeneca Press Release - Covid 19

ASZ Logo

Dear CBI members and Partners,

Kindly find CBI member AstraZeneca's press release relating to their  AZD7442 PROVENT Phase III prophylaxis trial.

Download AZD7442 PROVENT P3 HLR_FINAL

Our thanks to AstraZeneca's China team for kindly sharing this information.

Posted on 08 September 2021 at 10:29 in British Business, CBI China, COVID-19, Pharmaceutical Sector, UK-CHINA Relations |

|

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Verify your Comment

Previewing your Comment

Posted by:  | 

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name and email address are required. Email address will not be displayed with the comment.)

March 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Categories

About